Developers: | Stevens Institute of Technology |
Branches: | Manufacturers of medical products, Pharmaceuticals, medicine, healthcare |
Content |
History
2022: Start selling a portable scanner
In May 2022, the Stevens Institute of Technology announced the sale of a portable device, which, according to the developers, will halve the number of unnecessary biopsies in skin cancer. The device will also provide dermatologists and other physicians with easy access to laboratory cancer diagnosis.
The device developed by the team uses millimeter wave imaging - the same technology used in airport security scanners to scan a patient's skin. When using the device, healthy tissue reflects the rays of millimeter waves differently from cancer tissue, so doctors can detect cancer by tracking the contrast of rays reflected from the skin.
To introduce this device into clinical practice, the researchers used algorithms to combine signals obtained from different antennas into a single image with ultra-high throughput, which made it possible to reduce noise and quickly obtain high-resolution images of even the smallest mole or spot.
The research team used a desktop version of their technology to study 71 patients during clinical visits and found that their method allows for the correct distinction between benign and malignant formations in a very short time. Using their device, the researchers were able to detect a cancerous skin tumor in a few seconds.
{{quote 'Commenting on the development results, Tavassolian said: There are other advanced imaging technologies that can detect skin cancer, but these are large, expensive devices that are not used in clinics. We create an inexpensive device that is as small and easy to use as a cell phone, so we can make advanced diagnostics available to everyone. }} The next step of the researchers is to place a diagnostic command set on an integrated circuit, which will allow the production of functional portable diagnostic devices of millimeter waves at a price of $100 apiece. This is many times less than the cost of existing medical-grade diagnostic equipment. The research team is already working to commercialize its technology and hopes to begin providing these devices to doctors within the next two years.[1]